-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
4-Bromomethyl-2-methylthiopurine is a synthetic compound that is widely used in the chemical industry.
It is commonly used as an intermediate in the production of various chemicals, drugs, and other materials.
The synthetic routes of 4-bromomethyl-2-methylthiopurine can be broadly classified into two categories: direct synthesis and indirect synthesis.
Direct synthesis of 4-bromomethyl-2-methylthiopurine involves the synthesis of the compound from its individual constituents, using a series of chemical reactions.
The most common direct synthesis route involves the following steps:
- Synthesis of 2-methylthiopurine: This step involves the reduction of 2-chloromethyl-6-aminopurine to yield 2-methylthiopurine using a reducing agent such as lithium aluminum hydride (LiAlH4).
- Synthesis of 4-bromomethyl-2-methylthiopurine: The compound is synthesized by treating 2-methylthiopurine with bromine in the presence of a catalyst such as hydrogen bromide (HBr) or zinc bromide (ZnBr2).
- Purification of 4-bromomethyl-2-methylthiopurine: The final product is obtained by purifying the synthesized compound using methods such as filtration, crystallization, or chromatography.
Indirect synthesis of 4-bromomethyl-2-methylthiopurine involves the synthesis of the compound through a series of intermediate compounds.
The most common indirect synthesis route involves the following steps:
- Synthesis of 2-chloromethyl-6-aminopurine: This step involves the reaction of chloromethyl methyl ether with ammonia to yield 2-chloromethyl-6-aminopurine.
- Synthesis of 6-aminomethyl-2-chloropurine: The compound is synthesized by treating 2-chloromethyl-6-aminopurine with cyanogen bromide (CNBr2) in the presence of a catalyst such as sodium hydroxide (NaOH).
- Synthesis of 6-methyl-2-chloropurine: The compound is synthesized by treating 6-aminomethyl-2-chloropurine with methyl iodide (CH3I) in the presence of a catalyst such as sodium hydroxide (NaOH).
- Synthesis of 4-bromomethyl-2-methylthiopurine: The compound is synthesized by treating 6-methyl-2-chloropurine with thiophosphoryl chloride in the presence of a catalyst such as pyridine.
- Purification of 4-bromomethyl-2-methylthiopurine: The final product is obtained by purifying the synthesized compound using methods such as filtration, crystallization, or chromatography.
Both direct and indirect synthesis routes of 4-bromomethyl-2-methylthiopurine have their advantages and disadvantages.
Direct synthesis routes are generally simpler and more efficient, but may require specialized equipment and more hazardous reagents.
Indirect synthesis routes are more versatile and can lead to a range of related compounds, but may require more steps and more complex purification processes.
The choice of synthesis route depends on a variety of factors, including the availability of starting materials, the desired yield and purity of the final product, and the scale of production.
In practice,